https://www.eib.org/en/press/all/2019-058-marinomed-receives-eur-15m-eib-financing
Austria: Marinomed receives EUR 15m EIB financing
The EIB is providing EUR 15m to Marinomed Biotech AG, a Vienna-based biopharmaceutical company developing innovative therapies for allergy, respiratory and eye...
austriamarinomedreceiveseur15m
https://www.ig.com/au/shares/markets-shares/marinomed-biotech-ag
Trade Marinomed Biotech AG Shares | Live Marinomed Biotech AG Share Price | IG Australia | IG AU
Marinomed Biotech AG, formerly known as Marinomed Biotechnologie GmbH, is an Austria-based biopharmaceutical company. The Company operates in two... [AU]
live share priceig australiatrademarinomedbiotech
https://www.biospace.com/marinomed-biotech-ag-budesolv-with-a-strongly-decreased-dose-of-the-active-ingredient-compared-to-the-marketed-product-rhinocort-aqua-shows-pronounced-efficacy-already-after-first-application-clinical-validation-of-the-marinosolv-platform
Marinomed Biotech AG: Budesolv with a strongly decreased dose of the active ingredient compared to...
May 15, 2019 - The pivotal phase III study for Budesolv has provided Marinomed Biotech AG, a globally active biopharmaceutical company with headquarters in Vienna, with...
https://www.ig.com/ch/aktien/maerkte-aktien/marinomed-biotech-ag
Marinomed Biotech AG Aktien handeln | Marinomed Biotech AG Realtime Aktienkurs | IG Schweiz
Marinomed Biotech AG, formerly known as Marinomed Biotechnologie GmbH, is an Austria-based biopharmaceutical company. The Company operates in two... [CH]
aktien handelnmarinomedbiotechagrealtime
https://www.finanznachrichten.de/chart-tool/aktie/marinomed-biotech-ag.htm
MARINOMED BIOTECH Chartanalyse
Chart zur MARINOMED BIOTECH AG Aktie. Alle Charts zu Ihren Aktien.
marinomedbiotechchartanalyse